title: Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia.
authors.affiliation: MLL Munich Leukaemia Laboratory, Munich, Germany.
authors.forename: Marietta S
authors.initials: MS
authors.lastname: Truger
authors.forename: Sabine
authors.initials: S
authors.lastname: Jeromin
authors.forename: Sandra
authors.initials: S
authors.lastname: Weissmann
authors.forename: Frank
authors.initials: F
authors.lastname: Dicker
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Kern
authors.forename: Susanne
authors.initials: S
authors.lastname: Schnittger
authors.forename: Torsten
authors.initials: T
authors.lastname: Haferlach
authors.forename: Claudia
authors.initials: C
authors.lastname: Haferlach
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000401:mortality*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor
keywords: IGHV mutational status; TP53; chronic lymphocytic leukaemia; genetic abnormalities; prognostic markers